tiprankstipranks
Trending News
More News >
Allergy Therapeutics (GB:AGY)
:AGY
UK Market
Advertisement

Allergy Therapeutics (AGY) Drug Pipeline

Compare
16 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Pq Grass
Seasonal Allergic Rhinitis, Rhinoconjunctivitis
Phase III
Completed
Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
Sep 01, 2022
Vlp Peanut
Peanut Allergy
Phase I
Recruiting
Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects
Jul 08, 2022
Pq Grass
Rhinitis, Allergic, Seasonal
Phase II/III
Completed
An Exploratory Study of PQ Grass 27600 SU
Oct 08, 2020
Grass Mata Mpl
Seasonal Allergic Rhinitis
Phase I
Completed
A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
Mar 29, 2017
Grass Mata Mpl (0.5Ml) 5100Su, Grass Mata Mpl (1.0Ml) 10200Su, Grass Mata Mpl (1.0Ml) 18200Su, Grass Mata (0.5Ml) 5100Su
Seasonal Allergic Rhinitis
Phase II
Completed
Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™
Oct 20, 2015
Grass Mata Mpl 10200, Grass Mata Mpl 18200
Allergic Rhinitis
Phase I
Completed
A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
Sep 15, 2015
Tree Mata Mpl Or Tree Mata
Type I Hypersensitivity
Phase II
Terminated
Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis
Oct 12, 2006
Ragweedmatampl
Type I Hypersensitivity
Phase II
Completed
Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
Nov 25, 2005
Grass Matampl
Type I Hypersensitivity
Phase II
Completed
Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
Aug 22, 2005
Grass Mata Mpl
Type I Hypersensitivity
Phase II
Completed
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
Aug 22, 2005

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Allergy Therapeutics (AGY) have in its pipeline
      AGY is currently developing the following drugs: Pq Grass, Vlp Peanut, Pq Grass. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis